NeoVax, a personalised neoantigen vaccine, was safely combined with nivolumab in a phase 1 ovarian cancer trial published in Nature Medicine.
Trending
- Saturn Extends Its Lead With 274 Confirmed Moons
- Personalised Vaccine Safe With Immunotherapy in Early Ovarian Cancer Trial
- Slot Casino Games: What Happens During a Single Round?
- Advantages of Hiring Local Specialists for Sub-Zero Repairs in Austin
- Choosing UK Guest Posting Websites: A Practical Guide for Businesses
- Continuous Glucose Monitors Help Type 2 Diabetes Patients, Major Trial Finds
- SpaceX Launch Creates Stunning Jellyfish Cloud Over US East Coast
- Understanding Payment Processing Delays
